BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Zevra Therapeutics to Participate in the Guggenheim Healthcare Innovation Conference

  October 30, 2025

   · 

  2 min read
• Press Releases

  Reviva to Participate in the Spartan Capital Securities Second Annual Investor Conference

  October 30, 2025

   · 

  1 min read
• Press Releases

  OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th

  October 30, 2025

   · 

  1 min read
• Press Releases

  Belite Bio to Participate in the Deutsche Bank ADR Virtual Investor Conference

  October 30, 2025

   · 

  1 min read
• Press Releases

  Aclaris Therapeutics to Participate in Three November 2025 Healthcare Conferences

  October 30, 2025

   · 

  1 min read
• Press Releases

  Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results

  October 30, 2025

   · 

  1 min read
• Press Releases

  Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year

  October 30, 2025

   · 

  10 min read
• Press Releases

  U.S. FDA grants interchangeability designation to Celltrion’s denosumab biosimilars, STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo)

  October 30, 2025

   · 

  13 min read
• Press Releases

  GenSight Biologics Announces Regulatory Authorizations for Individual Patient Expanded Access Treatment with GS010/LUMEVOQ® in the US

  October 30, 2025

   · 

  4 min read
• Press Releases

  Oculis Announces Oversubscribed $110 Million Financing to Accelerate Privosegtor Development

  October 30, 2025

   · 

  7 min read